These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

282 related items for PubMed ID: 10487683

  • 1. Alterations in bone turnover and impaired development of bone mineral density in newly diagnosed children with cancer: a 1-year prospective study.
    Arikoski P, Komulainen J, Riikonen P, Voutilainen R, Knip M, Kröger H.
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3174-81. PubMed ID: 10487683
    [Abstract] [Full Text] [Related]

  • 2. Impaired development of bone mineral density during chemotherapy: a prospective analysis of 46 children newly diagnosed with cancer.
    Arikoski P, Komulainen J, Riikonen P, Parviainen M, Jurvelin JS, Voutilainen R, Kröger H.
    J Bone Miner Res; 1999 Dec; 14(12):2002-9. PubMed ID: 10620058
    [Abstract] [Full Text] [Related]

  • 3. Effects of intensive chemotherapy on bone and collagen turnover and the growth hormone axis in children with acute lymphoblastic leukemia.
    Crofton PM, Ahmed SF, Wade JC, Stephen R, Elmlinger MW, Ranke MB, Kelnar CJ, Wallace WH.
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3121-9. PubMed ID: 9745414
    [Abstract] [Full Text] [Related]

  • 4. Bone turnover and growth during and after continuing chemotherapy in children with acute lymphoblastic leukemia.
    Crofton PM, Ahmed SF, Wade JC, Elmlinger MW, Ranke MB, Kelnar CJ, Wallace WH.
    Pediatr Res; 2000 Oct; 48(4):490-6. PubMed ID: 11004240
    [Abstract] [Full Text] [Related]

  • 5. Effects of short-term recombinant human insulin-like growth factor I administration on bone turnover in osteopenic women with anorexia nervosa.
    Grinspoon S, Baum H, Lee K, Anderson E, Herzog D, Klibanski A.
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3864-70. PubMed ID: 8923830
    [Abstract] [Full Text] [Related]

  • 6. Analysis of bone mineral density and turnover in patients with cystic fibrosis: associations between the IGF system and inflammatory cytokines.
    Street ME, Spaggiari C, Ziveri MA, Volta C, Federico G, Baroncelli GI, Bernasconi S, Saggese G.
    Horm Res; 2006 Nov; 66(4):162-8. PubMed ID: 16804317
    [Abstract] [Full Text] [Related]

  • 7. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
    Garnero P, Sornay-Rendu E, Chapuy MC, Delmas PD.
    J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944
    [Abstract] [Full Text] [Related]

  • 8. Bone mineral density measured by dual-energy x-ray absorptiometry and novel markers of bone formation and resorption in patients on antiepileptic drugs.
    Välimäki MJ, Tiihonen M, Laitinen K, Tähtelä R, Kärkkäinen M, Lamberg-Allardt C, Mäkelä P, Tunninen R.
    J Bone Miner Res; 1994 May; 9(5):631-7. PubMed ID: 8053391
    [Abstract] [Full Text] [Related]

  • 9. Bone mineral density and body composition before and during treatment with gonadotropin-releasing hormone agonist in children with central precocious and early puberty.
    Boot AM, De Muinck Keizer-Schrama S, Pols HA, Krenning EP, Drop SL.
    J Clin Endocrinol Metab; 1998 Feb; 83(2):370-3. PubMed ID: 9467543
    [Abstract] [Full Text] [Related]

  • 10. Effects of 12 months of recombinant growth hormone therapy on parameters of bone metabolism and bone mineral density in patients on chronic hemodialysis.
    Kotzmann H, Riedl M, Pietschmann P, Schmidt A, Schuster E, Kreuzer S, Kainberger F, Frisch H, Geyer G, Hörl WH, Mayer G, Luger A.
    J Nephrol; 2004 Feb; 17(1):87-94. PubMed ID: 15151263
    [Abstract] [Full Text] [Related]

  • 11. Effects of suppression of estrogen action by the p450 aromatase inhibitor letrozole on bone mineral density and bone turnover in pubertal boys.
    Wickman S, Kajantie E, Dunkel L.
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3785-93. PubMed ID: 12915670
    [Abstract] [Full Text] [Related]

  • 12. Changes in the serum growth factors and osteoprotegerin after bone marrow transplantation: impact on bone and mineral metabolism.
    Baek KH, Lee WY, Oh KW, Kim HS, Han JH, Kang MI, Cha BY, Lee KW, Son HY, Kang SK, Kim CC.
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1246-54. PubMed ID: 15001618
    [Abstract] [Full Text] [Related]

  • 13. Bone mineral density and bone turnover before and after surgical cure of Cushing's syndrome.
    Hermus AR, Smals AG, Swinkels LM, Huysmans DA, Pieters GF, Sweep CF, Corstens FH, Kloppenborg PW.
    J Clin Endocrinol Metab; 1995 Oct; 80(10):2859-65. PubMed ID: 7559865
    [Abstract] [Full Text] [Related]

  • 14. [Bone mineral density and markers of bone turnover in patients treated for malignant disease in childhood].
    Muszyńska-Rosłan K, Konstantynowicz J, Krawczuk-Rybak M, Łuczyński W, Kaczmarski M, Wołczynski S, Piotrowska-Jastrzebska J.
    Med Wieku Rozwoj; 2004 Oct; 8(4 Pt 2):1041-54. PubMed ID: 15951599
    [Abstract] [Full Text] [Related]

  • 15. Osteoprotegerin and bone mass in squamous cell head and neck cancer patients.
    Valero C, Olmos JM, Rivera F, Hernández JL, Vega ME, Macías JG.
    Calcif Tissue Int; 2006 Jun; 78(6):343-7. PubMed ID: 16830204
    [Abstract] [Full Text] [Related]

  • 16. Comparative study of the changes in insulin-like growth factor-I, procollagen-III N-terminal extension peptide, bone Gla-protein, and bone mineral content in children with Turner's syndrome treated with recombinant growth hormone.
    Bergmann P, Valsamis J, Van Perborgh J, De Schepper J, Van Vliet G.
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1461-7. PubMed ID: 2229302
    [Abstract] [Full Text] [Related]

  • 17. Effects of 12 months rec-GH therapy on bone and collagen turnover and bone mineral density in GH deficient children with thalassaemia major.
    Sartorio A, Conte G, Conti A, Masala A, Alagna S, Rovasio P, Faglia G.
    J Endocrinol Invest; 2000 Jun; 23(6):356-61. PubMed ID: 10908162
    [Abstract] [Full Text] [Related]

  • 18. Decreased lumbar spine bone mass and low bone turnover in children and adolescents with insulin dependent diabetes mellitus followed longitudinally.
    Gunczler P, Lanes R, Paz-Martinez V, Martins R, Esaa S, Colmenares V, Weisinger JR.
    J Pediatr Endocrinol Metab; 1998 Jun; 11(3):413-9. PubMed ID: 11517957
    [Abstract] [Full Text] [Related]

  • 19. Insulin-like growth factor-I and bone mineral density.
    Collins D, Woods A, Herd R, Blake G, Fogelman I, Wheeler M, Swaminathan R.
    Bone; 1998 Jul; 23(1):13-6. PubMed ID: 9662125
    [Abstract] [Full Text] [Related]

  • 20. Biochemical bone markers and bone mineral density during postmenopausal hormone replacement therapy with and without vitamin D3: a prospective, controlled, randomized study.
    Heikkinen AM, Parviainen M, Niskanen L, Komulainen M, Tuppurainen MT, Kröger H, Saarikoski S.
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2476-82. PubMed ID: 9253321
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.